← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Aditya Birla Sun Life Pharma and Healthcare Fund

Regular Plan · IDCW · Sectoral / Thematic · Scheme code 147408

Fund houseAditya Birla Sun Life Mutual Fund
CategorySectoral / Thematic
Plan & optionRegular · IDCW
History7.1 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 1.5011.4117.90 11.8213.636.35 13.5613.18
Nifty 500
benchmark
0.874.312.15 5.2012.4911.41 15.49
Sectoral / Thematic
category median
5.6615.6212.90 13.92

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 16.2% 0.44 0.60 0.64 2.29% -30.6% 38.67
Nifty 500
benchmark
17.2%0.35 0.47 -37.3%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 83 months this scheme and its benchmark share.

Growth of ₹100 since launch

821391962542020202220242026InvestVerdict

Drawdown from peak (%)

0%-11%-22%-34%2020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
303 -21.7% 8.8% 54.1% 28%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Aditya Birla Sun Life Pharma and Healthcare Fund

Regular Plan · IDCW

Concentration

Number of stocks0
Top 5 stocks
Top 10 stocks
Top 20 stocks
Largest holding
Largest sector— —
Effective stocks
Cash0.00%
InvestVerdict

Aditya Birla Sun Life Pharma and Healthcare Fund

Regular Plan · IDCW · holdings

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹825,229 ₹225,229 12.72%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 29 Aug 2026.